Prediction: This Will Be the Best-Performing Growth Stock Over the Next 5 Years
Briefly

"None of the candidates listed are wildly speculative; they boast a history of strong revenue growth and are expected to continue this momentum over the next five years."
"Guardant Health's stock is projected to rise significantly, with analysts seeing its price potentially reaching $605 per share by 2028, showing robust expected revenue growth in the coming years."
"Braze, despite currently trading near a 52-week low, has a consensus target suggesting a substantial potential upside, underlining analysts' confidence in the customer engagement software market."
Read at 24/7 Wall St.
[
|
]